All In Biotech

Free tool

FAERS Monitor: Verelan

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019614 or its brand name (Verelan, Verapamil Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

4,312

Serious

3,916

91% of reports

Hospitalization

1,954

Death reported

958

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea357
  • nausea353
  • drug interaction316
  • dizziness293
  • hypotension287
  • fatigue277
  • diarrhoea271
  • abdominal pain245
  • vomiting244
  • cough242
  • headache238
  • fall237
  • completed suicide236
  • tachycardia230
  • asthenia229

Reports by year received

View as table
YearReports
200482
2005130
2006122
200758
200890
200953
201086
201179
2012112
201361
2014109
2015160
2016187
2017187
2018199
2019217
2020243
2021273
2022488
2023407
2024438
2025331
2026200

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,847 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
completed suicideSignal23613.912.22,804
tachycardiaSignal23012.711.22,462
drug interactionSignal3169.78.82,481
hypotensionSignal2877.06.21,478
abdominal painSignal2455.14.6821
coughSignal2424.23.7597
fallSignal2373.53.1422
dyspnoeaSignal3573.12.8512
astheniaSignal2293.02.6303
dizzinessSignal2932.92.6363
vomitingSignal2442.52.2230
nauseaSignal3532.22.0232
diarrhoeaSignal2712.01.8149
headache2381.91.695
fatigue2771.71.589

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.